Published in Angew Chem Int Ed Engl on December 11, 2006
Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev (2008) 4.80
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano (2008) 3.88
Multimodality imaging probes: design and challenges. Chem Rev (2010) 2.61
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol (2008) 1.59
Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells. Angew Chem Int Ed Engl (2010) 1.25
Multimodality Imaging of Integrin α(v)β(3) Expression. Theranostics (2011) 1.10
Preparation of Fe₃O₄ magnetic nanoparticles coated with gallic acid for drug delivery. Int J Nanomedicine (2012) 1.09
Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev (2013) 1.07
Correlated biofilm imaging, transport and metabolism measurements via combined nuclear magnetic resonance and confocal microscopy. ISME J (2007) 1.04
Multifunctional Particles: Magnetic Nanocrystals and Gold Nanorods Coated with Fluorescent Dye-Doped Silica Shells. J Solid State Chem (2008) 1.00
Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery. J Am Ceram Soc (2009) 0.97
Labeling human mesenchymal stem cells with gold nanocages for in vitro and in vivo tracking by two-photon microscopy and photoacoustic microscopy. Theranostics (2013) 0.96
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage (2010) 0.95
Manganese displacement from Zinpyr-1 allows zinc detection by fluorescence microscopy and magnetic resonance imaging. Chem Commun (Camb) (2010) 0.92
Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells (2013) 0.91
Synthesis of Organic Dye-Impregnated Silica Shell-Coated Iron Oxide Nanoparticles by a New Method. Nanoscale Res Lett (2008) 0.84
Theranostic Magnetic Nanostructures (MNS) for Cancer. Cancer Treat Res (2015) 0.81
Synthesis and characterization of multifunctional silica core-shell nanocomposites with magnetic and fluorescent functionalities. J Magn Magn Mater (2009) 0.77
Controllable in situ synthesis of magnetite coated silica-core water-dispersible hybrid nanomaterials. Langmuir (2013) 0.76
Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor. J Nanobiotechnology (2016) 0.76
Exploiting Size-Dependent Drag and Magnetic Forces for Size-Specific Separation of Magnetic Nanoparticles. Int J Mol Sci (2015) 0.75
Modulation of Silica Nanoparticle Uptake into Human Osteoblast Cells by Variation of the Ratio of Amino and Sulfonate Surface Groups: Effects of Serum. ACS Appl Mater Interfaces (2015) 0.75
Lanthanide sorbent based on magnetite nanoparticles functionalized with organophosphorus extractants. Sci Technol Adv Mater (2015) 0.75
Recent development of nanoparticles for molecular imaging. Philos Trans A Math Phys Eng Sci (2017) 0.75
Thiol-ene click chemistry: a biocompatible way for orthogonal bioconjugation of colloidal nanoparticles. Chem Sci (2017) 0.75
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med (2006) 7.05
Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc (2005) 3.67
Observation of single colloidal platinum nanocrystal growth trajectories. Science (2009) 2.89
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc (2005) 2.83
Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed Engl (2008) 2.59
Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol (2011) 2.45
Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc Chem Res (2008) 2.37
Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J Am Chem Soc (2005) 2.25
Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol (2006) 2.14
Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc (2010) 2.00
High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol (2008) 1.88
Theranostic magnetic nanoparticles. Acc Chem Res (2011) 1.84
All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl (2009) 1.77
Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew Chem Int Ed Engl (2009) 1.57
Epithelial Na+ channel proteins are mechanotransducers of myogenic constriction in rat posterior cerebral arteries. Exp Physiol (2011) 1.54
A magnetic switch for the control of cell death signalling in in vitro and in vivo systems. Nat Mater (2012) 1.40
Size dependent macrophage responses and toxicological effects of Ag nanoparticles. Chem Commun (Camb) (2011) 1.39
HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol (2009) 1.35
A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging. Angew Chem Int Ed Engl (2008) 1.34
Biocompatible heterostructured nanoparticles for multimodal biological detection. J Am Chem Soc (2006) 1.28
Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol (2004) 1.21
Interactions between Shh, Sostdc1 and Wnt signaling and a new feedback loop for spatial patterning of the teeth. Development (2011) 1.21
Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology (2008) 1.11
Shape control of semiconductor and metal oxide nanocrystals through nonhydrolytic colloidal routes. Angew Chem Int Ed Engl (2006) 1.10
Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis. Nano Lett (2012) 1.07
Self-confirming "AND" logic nanoparticles for fault-free MRI. J Am Chem Soc (2010) 1.07
Artificial control of cell signaling and growth by magnetic nanoparticles. Angew Chem Int Ed Engl (2010) 1.07
Superlattice and magnetism directed by the size and shape of nanocrystals. Chemphyschem (2002) 1.06
Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol (2006) 1.03
Nanoparticle assemblies as memristors. Nano Lett (2009) 1.00
Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model. Eur J Immunol (2011) 0.99
Recent advances in magnetic nanoparticle-based multi-modal imaging. Chem Soc Rev (2015) 0.99
High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun (2012) 0.97
Development of water-soluble single-crystalline TiO2 nanoparticles for photocatalytic cancer-cell treatment. Small (2007) 0.97
MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction. Cancer Discov (2013) 0.96
Theranostic nanomedicine. Acc Chem Res (2011) 0.96
The concept of delayed nucleation in nanocrystal growth demonstrated for the case of iron oxide nanodisks. J Am Chem Soc (2006) 0.96
Single-crystalline star-shaped nanocrystals and their evolution: programming the geometry of nano-building blocks. J Am Chem Soc (2002) 0.95
Magnetophoretic immunoassay of allergen-specific IgE in an enhanced magnetic field gradient. Anal Chem (2007) 0.95
Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation (2011) 0.94
Formation of targeted monovalent quantum dots by steric exclusion. Nat Methods (2013) 0.93
Surfactant-assisted elimination of a high energy facet as a means of controlling the shapes of TiO2 nanocrystals. J Am Chem Soc (2003) 0.92
Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers. Lab Invest (2009) 0.92
Heterostructured magnetic nanoparticles: their versatility and high performance capabilities. Chem Commun (Camb) (2006) 0.92
Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells (2013) 0.91
[Association between CCR5 promoter polymorphisms and hepatitis B virus infection]. Korean J Hepatol (2005) 0.90
Double-effector nanoparticles: a synergistic approach to apoptotic hyperthermia. Angew Chem Int Ed Engl (2012) 0.89
Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates. J Immunol (2013) 0.89
Distinguishing between apoptosis and necrosis using a capacitance sensor. Biosens Bioelectron (2009) 0.88
Sterically induced shape and crystalline phase control of GaP nanocrystals. J Am Chem Soc (2002) 0.87
Capacitance-based assay for real-time monitoring of endocytosis and cell viability. Lab Chip (2012) 0.87
Autonomous isolation, long-term culture and differentiation potential of adult salivary gland-derived stem/progenitor cells. J Tissue Eng Regen Med (2012) 0.87
Chemical synthetic strategy for single-layer transition-metal chalcogenides. J Am Chem Soc (2014) 0.85
In situ one-pot synthesis of 1-dimensional transition metal oxide nanocrystals. J Phys Chem B (2005) 0.85
Two-dimensional nanosheet crystals. Angew Chem Int Ed Engl (2007) 0.85
Cloning of TLR3 isoform. Yonsei Med J (2004) 0.85
Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. Angew Chem Int Ed Engl (2013) 0.85
Two novel mutations of Wiskott-Aldrich syndrome: the molecular prediction of interaction between the mutated WASP L101P with WASP-interacting protein by molecular modeling. Biochim Biophys Acta (2004) 0.84
The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries. PLoS One (2012) 0.83
CKD712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, inhibits the lipopolysaccharide-stimulated secretion of HMGB1 by inhibiting PI3K and classical protein kinase C. Int Immunopharmacol (2011) 0.83
Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease. Yonsei Med J (2009) 0.83
Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation. J Neurooncol (2002) 0.82
Characterization of superparamagnetic "core-shell" nanoparticles and monitoring their anisotropic phase transition to ferromagnetic "solid solution" nanoalloys. J Am Chem Soc (2004) 0.82
Redox-transmetalation process as a generalized synthetic strategy for core-shell magnetic nanoparticles. J Am Chem Soc (2005) 0.82
Magnetic properties of annealed core-shell CoPt nanoparticles. Nano Lett (2012) 0.81
Massive fabrication of free-standing one-dimensional Co/Pt nanostructures and modulation of ferromagnetism via a programmable barcode layer effect. Nano Lett (2005) 0.81
Design considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homing. ACS Nano (2014) 0.80
Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid beta self-assembly. Chem Commun (Camb) (2008) 0.80
HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2. J Innate Immun (2015) 0.80
Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide. Yonsei Med J (2004) 0.80
Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease. Eur J Pediatr (2009) 0.80
In vivo pulsed magneto-motive ultrasound imaging using high-performance magnetoactive contrast nanoagents. Nanoscale (2013) 0.79
Ultrathin zirconium disulfide nanodiscs. J Am Chem Soc (2011) 0.79
Magnetic actuation of hair cells. Appl Phys Lett (2011) 0.79
Development of monoclonal antibodies against human IRF-5 and their use in identifying the binding of IRF-5 to nuclear import proteins karyopherin-alpha1 and -beta1. Yonsei Med J (2008) 0.79
T₁ and T₂ dual-mode MRI contrast agent for enhancing accuracy by engineered nanomaterials. ACS Nano (2014) 0.79
Over-expression of S100B protein in children with cerebral palsy or delayed development. Brain Dev (2004) 0.79
Architectural control of magnetic semiconductor nanocrystals. J Am Chem Soc (2002) 0.79
Transformative two-dimensional layered nanocrystals. J Am Chem Soc (2011) 0.78
A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB). Chem Commun (Camb) (2011) 0.78
Highly crystalline anisotropic superstructures via magnetic field induced nanoparticle assembly. Chem Commun (Camb) (2007) 0.78
Magnetic nanoparticles for ultrafast mechanical control of inner ear hair cells. ACS Nano (2014) 0.78